Khasraw, M., Singh, K., Foster, M., Violette, M., Corcoran, A., Hotchkiss, K., … Fecci, P. (2025). A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma. Springer Science and Business Media LLC. https://doi.org/10.21203/rs.3.rs-5822396/v1

Khasraw, Mustafa, Kirit Singh, Matthew Foster, Marlene Violette, Anna Corcoran, Kelly Hotchkiss, Chelsea Railton, et al. “A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma.” Springer Science and Business Media LLC, January 22, 2025. https://doi.org/10.21203/rs.3.rs-5822396/v1.

Khasraw M, Singh K, Foster M, Violette M, Corcoran A, Hotchkiss K, et al. A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma. Springer Science and Business Media LLC. 2025.

Khasraw, Mustafa, et al. “A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma.” Springer Science and Business Media LLC, 22 Jan. 2025. Crossref, doi:10.21203/rs.3.rs-5822396/v1.

Khasraw M, Singh K, Foster M, Violette M, Corcoran A, Hotchkiss K, Railton C, Blandford E, Blethen K, Thomas E, Ashley D, Desjardins A, Friedman H, Johnson M, Friedman A, Keir S, Buckley E, Herndon J, McLendon R, Sampson J, Calabrese E, Lopez G, Grant G, Patel A, Gregory S, Li C-Y, Fecci P. A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma. Springer Science and Business Media LLC. 2025.